InvestorsHub Logo
Followers 18
Posts 642
Boards Moderated 0
Alias Born 05/19/2017

Re: None

Monday, 06/14/2021 5:38:32 PM

Monday, June 14, 2021 5:38:32 PM

Post# of 8504
I WANT THIS SHOT!

COVID-19 vaccine candidate efficacy in those 18 to <65 years old was preserved in influenza vaccine recipients

- Influenza vaccine immunogenicity preserved

- Study demonstrated no early safety concerns

- Data available ahead of publication via preprint server, medRxiv

http://ir.novavax.com/news-releases/news-release-details/novavax-announces-positive-results-first-study-influenza-vaccine
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News